CIK 0001625101 · Non-accelerated filer<br>Smaller reporting company
PULSE BIOSCIENCES, INC.
Sign in to watch- Ticker
- PLSE
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465696597
- Phone
- 510-906-4600
- Business address
- 3957 POINT EDEN WAY, HAYWARD, CA, 94545
- Former names
- Electroblate, Inc.
- Open-market buys, last 90 days
- $199,937
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$199,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-16 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $16.28 | $407K | 122,872 |
| 2025-09-16 | UECKER DARRIN Chief Technology Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 81,534 | ||
| 2025-09-15 | UECKER DARRIN Chief Technology Officer | Option exercise 10b5-1 | +25,000 | $4.00 | $100K | 147,872 |
| 2025-09-15 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $15.77 | $394K | 122,872 |
| 2025-09-15 | UECKER DARRIN Chief Technology Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 106,534 | ||
| 2025-09-12 | UECKER DARRIN Chief Technology Officer | Option exercise 10b5-1 | +25,000 | $4.00 | $100K | 147,872 |
| 2025-09-12 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $14.32 | $358K | 122,872 |
| 2025-09-12 | UECKER DARRIN Chief Technology Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 131,534 | ||
| 2025-09-11 | UECKER DARRIN Chief Technology Officer | Option exercise 10b5-1 | +25,000 | $4.00 | $100K | 147,872 |
| 2025-09-11 | UECKER DARRIN Chief Technology Officer | Sale 10b5-1 | −25,000 | $14.78 | $370K | 122,872 |
| 2025-09-11 | UECKER DARRIN Chief Technology Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 156,534 | ||
| 2025-09-10 | DUGGAN ROBERT W Director | Purchase | +34,659 | $14.66 | $508K | 47,551,200 |
| 2025-08-15 | van den Broek Richard Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-08-15 | Zanganeh Mahkam Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-08-15 | Zanganeh Mahkam Director | Grant or award · Stock Option (right to buy) | +24,134 | 24,134 | ||
| 2025-08-15 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-08-15 | DUGGAN ROBERT W Director | Grant or award · Stock Option (right to buy) | +20,792 | 20,792 | ||
| 2025-08-15 | Soni Manmeet Singh Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2025-07-14 | Weber Steven Principal Accounting Officer | Grant or award · Stock Option (right to buy) | +55,000 | 55,000 | ||
| 2025-06-13 | UECKER DARRIN Chief Technology Officer | Sale | −15,000 | $15.98 | $240K | 122,872 |
Page 4 of 15 · 292 trades